Apostolidis, Christos

Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding

Kratochwil, C., Bruchertseifer, F., Rathke, H., Bronzel, M., Apostolidis, C., Weichert, W., Haberkorn, U., Giesel, F. L., & Morgenstern, A. (2017) · Journal of Nuclear Medicine

Radiopharmaceutical Chemistry and ApplicationsProstate Cancer Diagnosis and Treatment

Cited by 505

Production of Ac-225 from Th-229 for Targeted α Therapy

Apostolidis, C., Molinet, R., Rasmussen, G., & Morgenstern, A. (2005) · Analytical Chemistry

Radiopharmaceutical Chemistry and ApplicationsRadioactive element chemistry and processing

Cited by 215

Cyclotron production of Ac-225 for targeted alpha therapy11Dedicated to Prof. Dr. Franz Baumgärtner on the occasion of his 75th birthday.

Apostolidis, C., Molinet, R., McGinley, J., Abbas, K., Möllenbeck, J., & Morgenstern, A. (2005) · Applied Radiation and Isotopes

Radiopharmaceutical Chemistry and ApplicationsNuclear physics research studies

Cited by 176

Supply and clinical application of Actinium-225 and Bismuth-213.

Morgenstern, A., Apostolidis, C., & Bruchertseifer, F. (2020) · Seminars in Nuclear Medicine

Radiopharmaceutical Chemistry and ApplicationsChemical Reactions and Isotopes

Cited by 141

An Improved Method for the Production of Ac-225/Bi-213 from Th-229 for Targeted Alpha Therapy.

Zielinska, B., Apostolidis, C., Bruchertseifer, F., & Morgenstern, A. (2007) · Solvent Extraction and Ion Exchange

Radiopharmaceutical Chemistry and ApplicationsRadioactive element chemistry and processing

Cited by 100

Targeted alpha therapy with 213Bi.

Morgenstern, A., Bruchertseifer, F., & Apostolidis, C. (2011) · Current Radiopharmaceuticalse

Radiopharmaceutical Chemistry and ApplicationsRadioactivity and Radon Measurements

Cited by 58